CorMedix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CorMedix and other ETFs, options, and stocks.

About CRMD

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. 

CEO
Joseph Todisco
CEOJoseph Todisco
Employees
191
Employees191
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
2006
Founded2006
Employees
191
Employees191

CRMD Key Statistics

Market cap
638.75M
Market cap638.75M
Price-Earnings ratio
3.91
Price-Earnings ratio3.91
Dividend yield
Dividend yield
Average volume
2.03M
Average volume2.03M
High today
$8.41
High today$8.41
Low today
$8.16
Low today$8.16
Open price
$8.27
Open price$8.27
Volume
1.48M
Volume1.48M
52 Week high
$14.96
52 Week high$14.96
52 Week low
$6.13
52 Week low$6.13

Stock Snapshot

With a market cap of 638.75M, CorMedix(CRMD) trades at $8.20. The stock has a price-to-earnings ratio of 3.91.

As of 2026-08-22, CorMedix(CRMD) stock has fluctuated between $8.16 and $8.41. The current price stands at $8.20, placing the stock +0.6% above today's low and -2.5% off the high.

CorMedix(CRMD) shares are trading with a volume of 1.48M, against a daily average of 2.03M.

During the past year, CorMedix(CRMD) stock moved between $6.13 at its lowest and $14.96 at its peak.

During the past year, CorMedix(CRMD) stock moved between $6.13 at its lowest and $14.96 at its peak.

CRMD News

TipRanks 1d
Cormedix Inc. Earnings Call Signals Strong Growth

Cormedix Inc. ((CRMD)) has held its Q2 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks Unlock powerful investin...

The Motley Fool 2d
CorMedix Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, Aug. 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Joseph Todisco EVP and Chief Op...

CorMedix Q2 2026 Earnings Call Transcript
Zacks 2d
Wall Street Analysts Believe CorMedix Could Rally 65.96%: Here's is How to Trade - Zacks Investment Research

...

Wall Street Analysts Believe CorMedix Could Rally 65.96%: Here's is How to Trade - Zacks Investment Research

People also own

Based on the portfolios of people who own CRMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.